Free Trial
OTCMKTS:ALPMY

Astellas Pharma (ALPMY) Stock Price, News & Analysis

Astellas Pharma logo
$9.60 -0.05 (-0.52%)
As of 07/3/2025 12:53 PM Eastern

About Astellas Pharma Stock (OTCMKTS:ALPMY)

Key Stats

Today's Range
$9.59
$9.98
50-Day Range
$9.12
$10.15
52-Week Range
$8.37
$13.14
Volume
41,054 shs
Average Volume
133,851 shs
Market Capitalization
N/A
P/E Ratio
56.47
Dividend Yield
3.65%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALPMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter.

ALPMY Stock News Headlines

Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
See More Headlines

ALPMY Stock Analysis - Frequently Asked Questions

Astellas Pharma's stock was trading at $9.66 on January 1st, 2025. Since then, ALPMY stock has decreased by 0.6% and is now trading at $9.60.

Astellas Pharma Inc. (OTCMKTS:ALPMY) released its quarterly earnings results on Friday, April, 25th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.12. The firm had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.02 billion. Astellas Pharma had a net margin of 2.65% and a trailing twelve-month return on equity of 16.55%.

Shares of Astellas Pharma split on the morning of Wednesday, April 2nd 2014.The 5-4 split was announced on Friday, March 14th 2014. The newly created shares were issued to shareholders after the closing bell on Tuesday, April 1st 2014. An investor that had 100 shares of stock prior to the split would have 125 shares after the split.

The following companies are subsidiaries of Astellas Pharma: Iota Biosciences, Nanna Therapeutics, Xyphos, Audentes Therapeutics, Potenza Therapeutics, Quethera, Universal Cells Inc., and others.

Shares of ALPMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/25/2025
Today
7/05/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:ALPMY
Fax
N/A
Employees
14,754
Year Founded
1923

Profitability

Trailing P/E Ratio
56.47
Forward P/E Ratio
22.86
P/E Growth
N/A
Net Income
$334.93 million
Pretax Margin
1.63%

Debt

Sales & Book Value

Annual Sales
$12.56 billion
Cash Flow
$1.80 per share
Price / Cash Flow
5.34
Book Value
$5.52 per share
Price / Book
1.74

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.23

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:ALPMY) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners